Studi clinici su BPCO nello stato di North Carolina
22 studi su BPCO cercano partecipanti presso sedi nello stato di North Carolina.
Città nello stato di North Carolina
Testo ufficiale dello studio (inglese)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- East Carolina University- Site Number : 8400102, Greenville
- Piedmont Healthcare - Family Medicine- Site Number : 8400022, Statesville
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Carolina Research Center, Inc., Shelby
In reclutamentoFase 2
Età da 40 a 85 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07684820A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- American Health Research - Charlotte- Site Number : 8400013, Charlotte
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
In reclutamentoFase 4
Età da 40 a 85 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Duke Asthma, Allergy and Airway Center- Site Number : 8400047, Durham
- Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013, Hickory
- Science 37, Llc- Site Number : 8400154, Morrisville
- e altri 1
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07190209A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Charlotte
In reclutamentoFase 2
Età da 40 a 80 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Southeastern Research Center, Winston-Salem
In reclutamentoFase 4
Età 60 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07816835A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, New Bern
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Charlotte
- Research Site, Concord
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, High Point
- Research Site, Kings Mountain
- Research Site, New Bern
- e altri 1
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of North Carolina Clinical Research Center, Chapel Hill
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06603246The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- Duke, Durham
In reclutamentoStudio osservazionale
Età 40 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
In reclutamentoFase 2/3
Età da 35 a 80 · Tutti i sessi · Aggiornato il 31 ago 2026 · NCT07363694Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
- Duke Asthma Allergy and Airway Center, Durham
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07037836Photon-counting CT in Chest Imaging
- Duke University Hospital, Durham
In reclutamento
Tutte le età · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT07031336A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Greensboro
- Research Site, Greenville
- Research Site, Huntersville
- e altri 3
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT06283966STRIVE Post-Market Registry Study
- Duke University Medical Center, Durham
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
In reclutamentoFase 3
Età da 40 a 75 · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT07177339SPIROMICS Study of Early COPD Progression (SOURCE)
- Wake Forest, Winston-Salem
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 30 a 55 · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Wake Forest School of Medicine, Salem
In reclutamento
Età da 40 a 80 · Tutti i sessi · Aggiornato il 28 apr 2026 · NCT07051707Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Shelby
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 9 apr 2026 · NCT06961214Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 feb 2026 · NCT04778046Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Wakemed, Raleigh
In reclutamentoStudio osservazionale
Età 50 e oltre · Tutti i sessi · Aggiornato il 5 ago 2025 · NCT06122077Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.